文献速递慢阻肺

呼吸肌力可预测慢阻肺急性加重

Respiratory Muscle Strength as a Predictor of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease.
PubMed 文献 · Respirology · 2025-02-26

该回顾性研究纳入208例慢阻肺患者,测量呼吸肌力并分析其对中重度急性加重的影响。结果显示48.1%存在呼吸肌无力,低最大吸气压预测值是1年内中重度急性加重的独立危险因素(校正HR 0.521,95%CI 0.317-0.856)。呼吸肌功能可作为疾病状态和早期预后的标志。

要点

  • 48.1%的慢阻肺患者存在呼吸肌无力。
  • 低最大吸气压预测值独立预测1年内中重度急性加重。
  • 呼吸肌无力出现在系统性骨骼肌功能障碍早期,且与肌少症相关。

核心结论

  • 较低的呼吸肌力与慢阻肺急性加重风险增加相关。
  • 呼吸肌功能可作为慢阻肺疾病状态和早期预后的标志。

研究设计与样本

  • 分析呼吸肌力对中重度急性加重的影响,校正性别、年龄、FEV1占预计值百分比、握力和骨骼肌质量指数等混杂因素。

主要发现

  • 208例患者中48.1%(100例)存在呼吸肌无力。
  • Cox回归分析显示,低最大吸气压预测值是1年内中重度急性加重的独立危险因素(校正HR每增加1个标准差为0.521;95%CI 0.317-0.856)。
  • 约半数患者在轻度系统性骨骼肌功能障碍时已存在呼吸肌无力,肌少症患者呼吸肌无力比例更高。
  • 存在呼吸肌无力的患者中,1年内进展为系统性骨骼肌功能障碍的人数多于无呼吸肌无力者。

临床怎么用

  • 对慢阻肺患者应评估呼吸肌力,尤其是最大吸气压。
  • 低最大吸气压预测值提示1年内中重度急性加重风险增加,可辅助早期预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is closely related to skeletal muscle dysfunction, and the evaluation of respiratory muscle function has recently been recommended. We aimed to investigate the effects of respiratory muscle dysfunction on clinical outcomes. METHODS: We retrospectively reviewed the medical records of patients with COPD whose respiratory muscle strength was measured between June 2015 and December 2021. We then analysed the effects of respiratory muscle strength on moderate-to-severe exacerbations after adjusting for confounding factors, including sex, age, forced expiratory volume in 1-s percent predicted, hand grip strength, and skeletal muscle mass index. We also compared the temporal relationship between respiratory and systemic skeletal muscle dysfunctions. RESULTS: Respiratory muscle weakness (RMW) was observed in 48.1% (100) of the 208 patients. Low percent predicted maximal inspiratory pressure was an independent risk factor for moderate-to-severe exacerbations within 1 year in the Cox regression analysis (adjusted hazard ratio per 1 standard deviation increase, 0.521; 95% confidence interval, 0.317-0.856). Approximately half of the patients already exhibited RMW at the mild systemic skeletal muscle dysfunction, while those with sarcopenia had higher RMW rates. More patients with RMW experienced progressive systemic skeletal muscle dysfunction within 1 year compared to those without RMW. CONCLUSION: Lower respiratory muscle strength is associated with an increased risk of exacerbation. Respiratory muscle function could serve as a marker of disease status and early prognosis in COPD.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Furukawa, Miyamoto, Asai, et al. Respiratory Muscle Strength as a Predictor of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease. Respirology. 2025. PMID: 40009650. doi:10.1111/resp.70003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。